Novartis AG (NVS)
110.59
+1.24
(+1.13%)
USD |
NYSE |
Nov 04, 13:24
Novartis Market Cap: 221.10B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 218.62B |
| October 31, 2024 | 216.72B |
| October 30, 2024 | 219.74B |
| October 29, 2024 | 220.98B |
| October 28, 2024 | 231.18B |
| October 25, 2024 | 227.50B |
| October 24, 2024 | 226.18B |
| October 23, 2024 | 228.06B |
| October 22, 2024 | 228.56B |
| October 21, 2024 | 231.38B |
| October 18, 2024 | 234.27B |
| October 17, 2024 | 232.93B |
| October 16, 2024 | 233.05B |
| October 15, 2024 | 232.36B |
| October 14, 2024 | 232.52B |
| October 11, 2024 | 232.36B |
| October 10, 2024 | 229.54B |
| October 09, 2024 | 231.20B |
| October 08, 2024 | 227.46B |
| October 07, 2024 | 227.64B |
| October 04, 2024 | 227.82B |
| October 03, 2024 | 227.46B |
| October 02, 2024 | 228.86B |
| October 01, 2024 | 229.02B |
| September 30, 2024 | 229.96B |
| Date | Value |
|---|---|
| September 27, 2024 | 234.06B |
| September 26, 2024 | 234.06B |
| September 25, 2024 | 235.72B |
| September 24, 2024 | 235.70B |
| September 23, 2024 | 235.60B |
| September 20, 2024 | 234.73B |
| September 19, 2024 | 234.81B |
| September 18, 2024 | 234.79B |
| September 17, 2024 | 234.24B |
| September 16, 2024 | 236.77B |
| September 13, 2024 | 234.16B |
| September 12, 2024 | 234.28B |
| September 11, 2024 | 233.39B |
| September 10, 2024 | 236.86B |
| September 09, 2024 | 237.20B |
| September 06, 2024 | 236.17B |
| September 05, 2024 | 235.84B |
| September 04, 2024 | 241.69B |
| September 03, 2024 | 239.91B |
| August 30, 2024 | 244.75B |
| August 29, 2024 | 243.80B |
| August 28, 2024 | 242.91B |
| August 27, 2024 | 242.63B |
| August 26, 2024 | 241.23B |
| August 23, 2024 | 240.03B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
151.47B
Minimum
Mar 23 2020
244.75B
Maximum
Aug 30 2024
191.66B
Average
190.28B
Median
Jul 01 2020
Market Cap Benchmarks
| Amgen Inc | 170.61B |
| AstraZeneca PLC | 221.41B |
| Johnson & Johnson | 382.81B |
| Eli Lilly and Co | 767.18B |
| Merck & Co Inc | 256.76B |
Market Cap Related Metrics
| PE Ratio | 12.96 |
| PS Ratio | 4.541 |
| PEG Ratio | 0.1002 |
| Price to Book Value | 5.104 |
| Price to Free Cash Flow | 18.13 |
| Price | 110.59 |
| Earnings Yield | 7.71% |
| PEGY Ratio | 0.0977 |
| Operating PE Ratio | 16.68 |
| Normalized PE Ratio | 19.27 |